Logo image of ASTH

ASTRANA HEALTH INC (ASTH) Stock Price, Forecast & Analysis

USA - NASDAQ:ASTH - US03763A2078 - Common Stock

23.8 USD
+1.37 (+6.11%)
Last: 11/11/2025, 5:52:19 PM
23.8 USD
0 (0%)
After Hours: 11/11/2025, 5:52:19 PM

ASTH Key Statistics, Chart & Performance

Key Statistics
Market Cap1.19B
Revenue(TTM)2.90B
Net Income(TTM)9.54M
Shares49.93M
Float38.91M
52 Week High45.16
52 Week Low21.2
Yearly Dividend0.09
Dividend YieldN/A
EPS(TTM)0.19
PE125.26
Fwd PE11.44
Earnings (Next)02-25 2026-02-25/amc
IPO1999-04-09
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services


ASTH short term performance overview.The bars show the price performance of ASTH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

ASTH long term performance overview.The bars show the price performance of ASTH in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of ASTH is 23.8 USD. In the past month the price decreased by -19.73%. In the past year, price decreased by -41.68%.

ASTRANA HEALTH INC / ASTH Daily stock chart

ASTH Latest News, Press Relases and Analysis

5 days ago - By: Zacks Investment Research - Mentions: AUNA
13 days ago - By: Zacks Investment Research - Mentions: DVA

ASTH Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CVS CVS HEALTH CORP 11.66 101.30B
CI THE CIGNA GROUP 9.43 71.54B
LH LABCORP HOLDINGS INC 16.95 22.29B
DGX QUEST DIAGNOSTICS INC 19.35 21.12B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 112.65 20.35B
GH GUARDANT HEALTH INC N/A 12.19B
HIMS HIMS & HERS HEALTH INC 73.61 8.98B
DVA DAVITA INC 13.25 8.74B
CHE CHEMED CORP 20.25 6.49B
RDNT RADNET INC 206.58 6.04B
BTSG BRIGHTSPRING HEALTH SERVICES 33.25 6.01B
OPCH OPTION CARE HEALTH INC 19.23 4.65B

About ASTH

Company Profile

ASTH logo image Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 1,900 full-time employees. The firm provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The firm's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. The company supports more than 20,000 providers.

Company Info

ASTRANA HEALTH INC

1668 S. Garfield Avenue, 2Nd Floor

Alhambra CALIFORNIA US

Employees: 1900

ASTH Company Website

ASTH Investor Relations

Phone: 16262820288

ASTRANA HEALTH INC / ASTH FAQ

Can you describe the business of ASTRANA HEALTH INC?

Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 1,900 full-time employees. The firm provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The firm's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. The company supports more than 20,000 providers.


What is the current price of ASTH stock?

The current stock price of ASTH is 23.8 USD. The price increased by 6.11% in the last trading session.


Does ASTRANA HEALTH INC pay dividends?

ASTH does not pay a dividend.


How is the ChartMill rating for ASTRANA HEALTH INC?

ASTH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


How is the market expecting ASTH stock to perform?

16 analysts have analysed ASTH and the average price target is 45.9 USD. This implies a price increase of 92.86% is expected in the next year compared to the current price of 23.8.


Can you provide the growth outlook for ASTRANA HEALTH INC?

The Revenue of ASTRANA HEALTH INC (ASTH) is expected to grow by 61.55% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the ownership details for ASTH stock?

You can find the ownership structure of ASTRANA HEALTH INC (ASTH) on the Ownership tab.


ASTH Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ASTH Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to ASTH. While ASTH is still in line with the averages on profitability rating, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ASTH Financial Highlights

Over the last trailing twelve months ASTH reported a non-GAAP Earnings per Share(EPS) of 0.19. The EPS decreased by -85.38% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.33%
ROA 0.43%
ROE 1.23%
Debt/Equity 1.29
Chartmill High Growth Momentum
EPS Q2Q%-96.97%
Sales Q2Q%99.71%
EPS 1Y (TTM)-85.38%
Revenue 1Y (TTM)68.17%

ASTH Forecast & Estimates

16 analysts have analysed ASTH and the average price target is 45.9 USD. This implies a price increase of 92.86% is expected in the next year compared to the current price of 23.8.

For the next year, analysts expect an EPS growth of 37.27% and a revenue growth 61.55% for ASTH


Analysts
Analysts85
Price Target45.9 (92.86%)
EPS Next Y37.27%
Revenue Next Year61.55%

ASTH Ownership

Ownership
Inst Owners53.14%
Ins Owners9.76%
Short Float %4.3%
Short Ratio5.12